GAMBALE, ELISABETTA
 Distribuzione geografica
Continente #
EU - Europa 295
NA - Nord America 234
AS - Asia 75
AF - Africa 2
SA - Sud America 1
Totale 607
Nazione #
US - Stati Uniti d'America 234
RU - Federazione Russa 176
IE - Irlanda 44
IT - Italia 39
SG - Singapore 26
HK - Hong Kong 19
CN - Cina 17
SE - Svezia 16
JO - Giordania 10
AT - Austria 7
FI - Finlandia 4
CH - Svizzera 3
DE - Germania 3
IN - India 3
CI - Costa d'Avorio 2
BR - Brasile 1
GB - Regno Unito 1
NL - Olanda 1
UA - Ucraina 1
Totale 607
Città #
Santa Clara 128
Dublin 44
Singapore 20
Florence 16
Hong Kong 12
Chandler 10
Ashburn 9
Vienna 7
Boardman 5
Los Angeles 5
Shanghai 5
Recanati 4
Bern 3
Bremen 3
Helsinki 3
Moscow 3
Pune 3
Abidjan 2
Altamura 2
Boston 2
Lawrence 2
Milan 2
Princeton 2
Yubileyny 2
Ann Arbor 1
Bologna 1
Buffalo 1
Cambridge 1
Campi Bisenzio 1
Fairfield 1
Hillsboro 1
Lappeenranta 1
San Diego 1
Seattle 1
Sulzano 1
São Paulo 1
Trumbull 1
Wilmington 1
Totale 308
Nome #
Association of systemic steroid treatment and outcome in patients treated with immune checkpoint inhibitors: A real-world analysis 90
Alteration of the Nucleotide Excision Repair (NER) Pathway in Soft Tissue Sarcoma 71
Pharmacogenomics of soft tissue sarcomas: New horizons to understand efficacy and toxicity 67
Castration-resistant prostate cancer with bone metastases: toward the best therapeutic choice 60
Immune checkpoint blockade with anti-programmed cell death 1 (PD-1) monoclonal antibody (mAb) cemiplimab: ongoing and future perspectives in rare genital cancers treatment 58
Safety of Immune Checkpoint Inhibitors in Elderly Patients: An Observational Study 54
Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors 52
Bone Metastases in Renal Cell Carcinoma: Impact of Immunotherapy on Survival 49
Effect of systemic therapies or best supportive care after disease progression to both nivolumab and cabozantinib in metastatic renal cell carcinoma: The Meet-Uro 19BEYOND study 47
Neutrophil-to-Eosinophil Ratio Predicts the Efficacy of Avelumab in Patients With Advanced Urothelial Carcinoma Enrolled in the MALVA Study (Meet-URO 25) 42
Successful Use of Cemiplimab in a Very Elderly Patient With Cutaneous Squamous Cell Carcinoma 38
Totale 628
Categoria #
all - tutte 3.145
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.145


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202213 0 0 0 0 0 0 0 5 0 2 2 4
2022/2023135 4 7 3 18 2 30 23 20 18 0 5 5
2023/202491 2 7 10 8 9 15 2 16 2 3 5 12
2024/2025389 21 64 45 110 149 0 0 0 0 0 0 0
Totale 628